We are delighted and honoured to announce our keynote speaker
Prof. Dr.
Fyodor Urnov
Innovative Genomics Institute at University of Berkeley, USA
CRISPR-Cas9 expert for patient therapies
CRISPR-Cas9 expert for patient therapies
Prof. Urnov is a specialist in genome editing with CRISPR-Cas9 which has transformed therapeutic advances in kidney care. The impact of gene therapy and immunotherapy already allows for first patient success stories for which Prof. Urnov’s colleagues Jennifer Doudna and Emmanuelle Charpentier received the Nobel Prize in Chemistry in 2020 for their pioneering work on CRISPR-Cas9. Along with such novel therapies, there is an urgent need to make such cures cost-effective and accessible for patients.
Join the session and learn more about the applications of CRISPR-Cas9 in kidney disease and therapies with Prof. Fyodor Urnov as well as Dr. Michael Curtis (President of R&D at eGenesis - project lead in the xenotransplantation program) and Ms. Fiona Loud (Policy Director, Kidney Care UK)
at Life/2021 nephrology congress
on Friday, September 17, 2021
Don´t miss the chance to explore "CRISPR-Cas9 in the renal arena - breaking down hurdles to new medicines and global transplant availability"
Life/2021 nephrology congress
September 15 - 18, 2021
33 days to go...
register now
Feel free to share the information about this
open-access educational symposium with your colleagues.
The Life/2021 congress 15/09/2021-18/09/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Please note: An administrative CME certification handling fee of 15 EUR + VAT will be charged in order to receive a certificate of attendance for attending EACCME® accredited sessions.